Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FDA8W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,445
Award facts
- Contract value 100% obligated
- $13,444.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,444.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML, a prescription pharmaceutical product. The award, issued on January 21, 2026, with completion expected by January 22, 2026, represents a non-set-aside competitive award with performance executed from the contractor's Conshohocken, Pennsylvania facility. This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99M through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, through its parent Cencora, Inc., is a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain. The company's extensive portfolio with the Defense Logistics Agency demonstrates its capability to efficiently fulfill government requirements for diverse pharmaceutical commodities across multiple therapeutic domains. This particular delivery order for SKYRIZI—a specialty medication used in dermatological treatment—exemplifies the company's role in supplying brand-name prescription medications to support military treatment facilities and other federal healthcare systems on a competitive, firm fixed-price basis.
Quick answers
Who was awarded contract SPE2DR26FDA8W?
SPE2DR26FDA8W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FDA8W worth?
The government has obligated $13,445 on SPE2DR26FDA8W.
Is contract SPE2DR26FDA8W an order under another contract?
Yes. SPE2DR26FDA8W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA8W competed?
The extent of competition for SPE2DR26FDA8W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award